Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled Trial

There are no US Food and Drug Administration-approved therapies for neonatal seizures. Phenobarbital and phenytoin frequently fail to control seizures. There are concerns about the safety of seizure medications in the developing brain. Levetiracetam has proven efficacy and an excellent safety profil...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Pediatrics (Evanston) Jg. 145; H. 6
Hauptverfasser:	Sharpe, Cynthia, Reiner, Gail E, Davis, Suzanne L, Nespeca, Mark, Gold, Jeffrey J, Rasmussen, Maynard, Kuperman, Rachel, Harbert, Mary Jo, Michelson, David, Joe, Priscilla, Wang, Sonya, Rismanchi, Neggy, Le, Ngoc Minh, Mower, Andrew, Kim, Jae, Battin, Malcolm R, Lane, Brian, Honold, Jose, Knodel, Ellen, Arnell, Kathy, Bridge, Renee, Lee, Lilly, Ernstrom, Karin, Raman, Rema, Haas, Richard H
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 01.06.2020
Schlagworte:	Anticonvulsants - therapeutic use Dose-Response Relationship, Drug Double-Blind Method Epilepsy, Benign Neonatal - diagnosis Epilepsy, Benign Neonatal - drug therapy Epilepsy, Benign Neonatal - physiopathology Female Humans Infant, Newborn Levetiracetam - therapeutic use Male Phenobarbital - therapeutic use Seizures - diagnosis Seizures - drug therapy Seizures - physiopathology
ISSN:	1098-4275, 1098-4275
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!